PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $165,000 | -88.9% | 23,198 | -62.7% | 0.00% | -80.0% |
Q4 2019 | $1,487,000 | +87.0% | 62,255 | +84.8% | 0.01% | +42.9% |
Q2 2016 | $795,000 | -69.3% | 33,685 | -73.5% | 0.01% | -72.0% |
Q1 2016 | $2,592,000 | -94.8% | 127,057 | -86.8% | 0.02% | -94.6% |
Q4 2015 | $49,573,000 | +200.2% | 963,524 | +148.7% | 0.46% | +129.1% |
Q3 2015 | $16,513,000 | -4.2% | 387,451 | +2.4% | 0.20% | -9.8% |
Q2 2015 | $17,236,000 | +52.8% | 378,399 | +27.3% | 0.22% | +53.1% |
Q1 2015 | $11,282,000 | +9796.5% | 297,219 | +7515.1% | 0.15% | +7250.0% |
Q2 2014 | $114,000 | – | 3,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |